Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28. Feb 2010 - :1537-4513 [PMID:20145548] [Rosenblatt J] [Wu Z] [Vasir B] [Zarwan C] [Stone R] [Mills H] [Friedman T] [Konstantinopoulos PA] [Spentzos D] [Ghebremichael M] [Stevenson K] [Neuberg D] [Levine JD] [Joyce R] [Tzachanis D] [Boussiotis V] [Kufe D] [Avigan D]
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells. Jun 2008 - J. Immunol.; 181(1):0022-1767 [PMID:18566447] [Vasir B] [Wu Z] [Crawford K] [Rosenblatt J] [Zarwan C] [Bissonnette A] [Kufe D] [Avigan D]
Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. Sep 2007 - J. Immunother.; 30(7):1524-9557 [PMID:17893567] [Avigan DE] [Vasir B] [George DJ] [Oh WK] [Atkins MB] [McDermott DF] [Kantoff PW] [Figlin RA] [Vasconcelles MJ] [Xu Y] [Kufe D] [Bukowski RM]
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. Jul 2004 - Clin. Cancer Res.; 10(14):1078-0432 [PMID:15269142] [Avigan D] [Vasir B] [Gong J] [Borges V] [Wu Z] [Uhl L] [Atkins M] [Mier J] [McDermott D] [Smith T] [Giallambardo N] [Stone C] [Schadt K] [Dolgoff J] [Tetreault JC] [Villarroel M] [Kufe D]
